For decades, scientists have searched for ways to stop Alzheimer’s disease before it destroys large areas of the brain.
While many treatments focus on removing harmful proteins or easing symptoms, researchers are increasingly asking another important question: how does the disease spread from one brain region to another?
A team at University of Utah Health believes they have found part of the answer. Their study, published in Cell, suggests that a normal brain protein called Arc may unintentionally help toxic Tau travel between nerve cells, allowing Alzheimer’s disease to gradually expand through the brain.
Healthy Tau proteins play an essential role by helping maintain the structure of neurons. During Alzheimer’s disease, however, Tau proteins become abnormal and stick together into tangled clumps. These tangles block the normal transport of nutrients and materials inside neurons, eventually causing the cells to die.
Scientists have long suspected that tiny pieces of abnormal Tau move into nearby healthy neurons, where they trigger the formation of new tangles. The new study provides evidence for how that journey may happen.
Arc normally supports learning and memory by allowing neurons to exchange information. It does this by packaging itself into microscopic bubbles called extracellular vesicles that travel from one cell to another. The researchers found that toxic Tau can hitch a ride inside these same vesicles.
Experiments in mice showed that vesicles carrying both Arc and Tau could infect healthy neurons and begin new Tau clumps. When the researchers genetically removed Arc, very little Tau entered these vesicles, and the spread of disease almost disappeared.
Interestingly, Arc also appeared to help damaged neurons survive by allowing them to export some toxic Tau. Without Arc, harmful Tau accumulated inside already sick neurons, causing them to die more rapidly. This surprising finding means future treatments may need to target the traveling Tau after it leaves diseased cells instead of blocking Arc completely.
The researchers also found similar vesicles containing Arc and Tau in human brain tissue. Although this does not prove the same process drives Alzheimer’s disease in people, it provides encouraging evidence that the mechanism may not be limited to mice.
If future research confirms these findings, scientists may eventually develop medicines that intercept Tau-filled vesicles before they infect neighboring brain cells. Such treatments would not restore neurons already lost, but they could potentially slow the progression of memory loss and preserve brain function for longer.
Because Alzheimer’s disease currently has no cure, slowing its spread would represent a major medical advance. Even delaying progression by a few years could improve quality of life for patients and reduce the burden on families and healthcare systems.
The research was published in Cell.
This study offers a fresh direction by focusing on disease transmission rather than simply removing Tau deposits. The biological evidence presented is strong, but the findings remain largely preclinical.
Human clinical studies will be essential before any treatment based on this discovery becomes possible. Overall, the research provides an exciting proof of concept that could inspire an entirely new generation of Alzheimer’s therapies.
If you care about Alzheimer’s, please read studies about the likely cause of Alzheimer’s disease , and new non-drug treatment that could help prevent Alzheimer’s.
For more health information, please see recent studies about diet that may help prevent Alzheimer’s, and results showing some dementia cases could be prevented by changing these 12 things.
Source: University of Utah Health.
